Search
for
Sort by
Research 121–150 of 1000+
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Biochemical and Clinical Effect of Ovarian Wedge Resection in the Polycystic Ovary Syndrome.
- Hirsuties
- Acne tarda: paplitimas, endokrininis ryšys, terapinės priemonės.
- Prostate cancer and androgenic alopecia
- Hirsutism
- Androgens and hair loss
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Normalized androgen ratio: its application to clinical dermatology
- The therapeutic use of androgens in women
- 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production
- British Hair and Nail Society
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Management of Polycystic Ovary Syndrome in Women by Implementing a Healthy Lifestyle and Effective Diet: A Review
- Enhancement of Intermittent Androgen Ablation Therapy by Finasteride Administration in Animal Models
- Hirsutism
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Androgen Conjugates: Physiology and Clinical Significance
- Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
- Clinical and epidemiological characteristics and condition of the hormonal status in women with androgenetic alopecia (1139.3)
- Germacrene Analogs are Anti-androgenic on Androgen-dependent Cells
- Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Long-Term Morbidity of PCOS
- Androgenetic alopecia - a literature review
- Pathogenesis of androgenetic alopecia
- Androgenetic Alopecia: How It Happens
- Sex hormones and related compounds, including hormonal contraceptives
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness